Trilagavit
Trilagavit is a medicine authorised by Swissmedic under authorisation number 35157. The authorisation holder is Lagap SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 December 1969 and the authorisation is valid without a time limit. ATC code A11DB places the medicine in the group Vitamins.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Trilagavit, compresse filmate | B | 15 December 1969 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | A11DB | 07.02.4. | B |
| 2 | 300 | Tablette(n) | A11DB | 07.02.4. | B |
| 18 | 15 | Tablette(n) | A11DB | 07.02.4. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Trilagavit authorised in Switzerland?
Yes. Trilagavit is authorised by Swissmedic under authorisation number 35157, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Trilagavit have?
Trilagavit is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Trilagavit?
The authorisation holder is Lagap SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.